Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43results about How to "Oral dose is small" patented technology

Self-microemulsifying nanocombination comprising lucid ganoderma total triterpene and jobstears seed oil and preparation method and application thereof

The invention relates to a self-microemulsifying nanocombination comprising lucid ganoderma total triterpene and jobstears seed oil and a preparation method and application thereof. The lucid ganoderma total triterpene and the jobstears seed oil are adopted as medicinal materials, the jobstears seed oil doubles as the oil phase, the mixture of surfactant and cosurfactant is adopted as medicine carrier, and the parts by weight are as follows: 15 parts of lucid ganoderma total triterpene, 45 to 150 parts of jobstears seed oil, 45 to 200 parts of surfactant and 20 to 100 parts of cosurfactant. The invention also discloses the preparation method and application of the self-microemulsifying nanocombination. The invention prepares the self-microemulsifying nanocombination with the water-insoluble medicinal lucid ganoderma total triterpene and the jobstears seed oil, wherein the jobstears seed oil has the effects of both medicine and adjuvant, so that the dosage of preparation adjuvant, and moreover, the jobstears seed oil and the lucid ganoderma total triterpene which are compatible have a synergistic antitumor effect. Meanwhile, the self-microemulsifying nanocombination can promote the absorption of medicines, so that the antitumor effect can be enhanced.
Owner:陈彦

Compound traditional Chinese medicine extract, as well as preparation method and application thereof

The invention provides a traditional Chinese medicine extract and a preparation method thereof. The compound traditional Chinese medicine extract is prepared from the following raw medicinal materials in parts by weight: 30-60 parts of astragalus membranaceus, 9-15 parts of glossy privet fruit, 9-30 parts of herba leonuri, 3-10 parts of fructus mume, 2-9 parts of coptis chinensis, 1-5 parts of cinnamon and 3-9 parts of butterflybush flower. The preparation method comprises the following steps: extracting volatile oil from cinnamon, and including the volatile oil by beta-cyclodextrin; extracting the cinnamon residue, astragalus membranaceus, glossy privet fruit, butterflybush flower and fructus mume by an ethanol solution I, and refining by means of macroporous adsorption resin to prepare dried extract powder 1; extracting the coptis chinensis and herba leonuri by an ethanol solution III, and refining by ion-exchange resin to prepare dried extract powder 2; and uniformly mixing the dried extract powder 1, the dried extract powder 2 and the volatile oil inclusion compound to obtain the compound traditional Chinese medicine extract. The preparation method is capable of remarkably improving the bioactive substance content and the pharmacologic action of the compound traditional Chinese medicine extract.
Owner:BEIJING HANDIAN PHARMA CO LTD

Oral insulin medicament and preparation method thereof

ActiveCN101590221AImprove bioavailabilityIn line with the physiological internal environmentPeptide/protein ingredientsMetabolism disorderCholic acidTherapeutic effect
The invention relates to an oral insulin medicament for treating type II diabetes, which contains insulin, primary bile acid, lecithin, cholesterol and bilirubin. The oral insulin medicament comprises the following components by weight: 1 weight portion of insulin, 30 to 100 weight portions of primary bile acid, 100 to 300 weight portions of lecithin, 1 to 3 weight portions of cholesterol, 0.08 to 0.8 weight portion of bilirubin, and 50 weight portions of bile acid. The invention prepares the insulin medicament which satisfies physiological characteristics of organisms according to the bionics, and proves the administration of the insulin medicament through an oral way has exact therapeutic effect on the type II diabetes through animal experiments and clinical trials. The medicament satisfies the physiological characteristics of the organisms, can ensure that blood sugar keeps relatively steady within 24 hours without hypoglycemic reaction, can also ensure that the lecithin in bodies of type II diabetic patients is reduced and the metabolic disturbance of the bile acid is gradually corrected when the blood sugar is reduced, and has preventing and treating effect on complicating diseases caused by the type II diabetes.
Owner:江苏平衡生物医药科技有限公司

Traditional Chinese medicine multicomponent micro-emulsion composition having function of resisting lung cancer, preparation method and application thereof in preparation of orally-taking lung cancer resistant medicine

The invention discloses a traditional Chinese medicine multicomponent micro-emulsion composition having a function of resisting lung cancer, a preparation method and application thereof in preparation of an orally-taking lung cancer resistant medicine. The application comprises the following steps of: adding ganoderma lucidum total triterpenes, coixenolide, ganoderan and semen coicis polysaccharide used as raw material medicines into a nano-medicine composition which consists of surfactants and cosurfactant, wherein the traditional Chinese medicine multicomponent micro-emulsion composition comprises the following components in parts by weight: 5-30 parts of ganoderma lucidum total triterpenes, 45-150 parts of coixenolide, 5-50 parts of ganoderan and 10-90 parts of semen coicis polysaccharide, 45-200 parts of surfactants, 20-100 parts of cosurfactant and 300-900 parts of distilled water. The invention also discloses a preparation method of the composition. The ganoderma lucidum total triterpenes and the coixenolide are carried into a non-water phase, and the lucid ganoderma and the semen coicis polysaccharide are carried into a water phase, so that the coixendide can be used as medicines and also can be used as an auxiliary; the polysaccharide can enhance the immunization and the stability of a micro-emulsion system; and by the micro-emulsion, the absorption of the ganoderma lucidum total triterpenes and coixenolide used as the lipid solubility components can be increased, and the matching of four components have a synergy anti-tumor effect so as to increase the anti-tumor effect.
Owner:陈彦

Traditional Chinese medicinal tablet for curing diabetic retinopathy and application thereof

The invention relates to a traditional Chinese medicinal tablet for curing diabetic retinopathy and an application thereof. A traditional Chinese medicinal tablet is provided. Raw medicines of the traditional Chinese medicinal tablet comprise, by weight, 30-60 parts of Radix Astragali, 9-15 parts of ligustrum lucidum, 9-30 parts of motherwort, 3-10 parts of dark plum, 2-9 parts of coptis, 1-5 parts of cortex cinnamomi and 3-9 parts of Buddleja officinalis. The traditional Chinese medicinal tablet is prepared by the following method: extracting volatile oil from cortex cinnamomi, and carrying out clathration on the volatile oil with beta-cyclodextrin; extracting cortex cinnamomi herbal residue, Radix Astragali, ligustrum lucidum, Buddleja officinalis and dark plum with an ethanol solution I, and refining with macroporous resin to obtain a dry extract powder 1; extracting coptis and motherwort with an ethanol solution III, and refining with ion exchange resin to obtain a dry extract powder 2; and adding auxiliary materials which are pharmaceutically acceptable into the dry extract powder 1, the dry extract powder 2 and a volatile oil clathrate, and carrying out tabletting to obtain the traditional Chinese medicinal tablet. In comparison with the prior art, the tablet provided by the invention has higher active material content in a unit preparation and has better pharmacological action.
Owner:BEIJING HANDIAN PHARMA CO LTD +1

A traditional Chinese medicine capsule for treating diabetic retinopathy and its application

The invention provides a traditional Chinese medicine capsule for treating diabetic retinopathy and an application of the traditional Chinese medicine capsule for treating diabetic retinopathy. The traditional Chinese medicine comprises the following raw materials in parts by weight: 30 to 60 parts of astragalus membranaceus, 9 to 15 parts of glossy privet fruit, 9 to 30 parts of leonurus, 3 to 10 parts of smoked plum, 2 to 9 parts of coptis chinensis, 1 to 5 parts of cortex cinnamomi and 3 to 9 parts of butterflybush flower. The preparation method of the capsule comprises the following steps: extracting a volatile oil from the cortex cinnamomi and enveloping the volatile oil with Beta-cyclodextrin; extracting medicinal residues of the cortex cinnamomi and the rest of medicinal materials by virtue of an ethanol solution with the volume percentage concentration of 30% to 80%; refining an extract with macroporous adsorption resin and drying so as to obtain dry extract powder; adding a volatile oil clathrate into the dry extract powder, evenly mixing, adding pharmaceutically acceptable auxiliary materials and filling into a capsule so as to obtain the traditional Chinese medicine capsule. Compared with the prior art, the content of active substances in the traditional Chinese medicine capsule provided by the invention is obviously improved, so that the obvious pharmacologic action of the traditional Chinese medicine capsule provided by the invention is achieved.
Owner:BEIJING HANDIAN PHARMA CO LTD +1

A traditional Chinese medicine tablet for treating diabetic retinopathy and its application

The present invention provides a traditional Chinese medicine tablet for treating diabetic retinopathy and its application, and provides a traditional Chinese medicine tablet. The raw materials of the traditional Chinese medicine tablet are composed of 30-60 parts by weight of Radix Astragali, 9-15 parts by weight of Ligustrum lucidum, 9-30 parts by weight of motherwort, 3-10 parts by weight of black plum, 2-9 parts by weight of coptis, 1-5 parts by weight of cinnamon, 3-9 parts by weight of Budisma; prepared by the following method: extract volatile oil from cinnamon, and use β- Cyclodextrin inclusion; cinnamon dregs, astragalus, Ligustrum lucidum, Mimenghua, and black plum are first extracted with ethanol solution I, and then refined with macroporous adsorption resin to obtain dry extract powder 1; Coptis chinensis and motherwort are first extracted with ethanol solution III extraction, and then refined by ion exchange resin, to obtain dry extract powder 2; dry extract powder 1, dry extract powder 2 and volatile oil inclusion compound, adding pharmaceutically acceptable excipients, and pressing into tablets to obtain the traditional Chinese medicine tablet. Compared with the prior art, the tablet of the invention has higher active substance content in the unit preparation and better pharmacological effect.
Owner:BEIJING HANDIAN PHARMA CO LTD +1

Blood fat-lowering and liver-protecting composite as well as preparation prepared thereby and preparation method of preparation

The invention provides a blood fat-lowering and liver-protecting composite as well as a preparation prepared thereby and a preparation method of the preparation, belonging to the technical field of traditional Chinese medicines. At present, in Chinese material medical preparations with the effects of lowering blood fat and protecting liver, most of the Chinese material medical preparations are costly prescription and has complicated components and backward process, contains nutritious components, and increases the load of the liver due to excessive components. The blood fat-lowering and liver-protecting composite provided by the invention comprises the following raw materials in parts by weight: 90-130 parts of pseudo-ginseng and 30-70 parts of tea. The preparation prepared from the composite comprises active ingredients and pharmaceutic adjuvants, wherein the active ingredients comprise the following components in parts by weight: 4-13 parts panax notoginseng saponins (PNS) and 2-8 parts of tea polyphenol (TP). The blood fat-lowering and liver-protecting composite and the preparation provided by the invention have the advantages of clear active ingredients, good stability, controllable quality and less dosage, and are convenient to use and carry.
Owner:SHENZHEN INST OF TECH

Post-ahypnia headache medicine and preparation method thereof

The invention discloses an ahypnia headache medicine and a preparation method of the medicine, and relates to a medicine for treating an ahypnia headache and a preparation method of the medicine. Themedicine solves the technical problems that the existing method for treating the post-ahypnia headache has a non-ideal medication effect, and especially, a western medicine has side effects of hypersomnia, dizziness and digestive disorders after long-term administration. The medicine comprises radix rehmanniae recen, Chinese angelica, spina date seeds, semen platycladi, polygala roots, rhizoma acori graminei, ligusticum wallichii and radix paeoniae alba. The preparation method comprises the steps of mixing the ligusticum wallichii, the spina date seeds, the Chinese angelica, the rhizoma acorigraminei, the semen platycladi and water for distillation and extraction, preparing a beta cyclodextrin inclusion compound, mixing and decocting decoction dreg after distillation with the radix rehmanniae recen, the radix paeoniae alba and the polygala roots, mixing a residual aqueous solution after the distillation with filtrate, performing pressure reduction concentration, standing, cooling to aroom temperature, adding ethanol, performing uniform mixing, refrigeration, filtration, pressure reduction, drying and grinding, and adding the beta cyclodextrin inclusion compound. The medicine hasan effective rate of 94.30% for treating the post-ahypnia headache, the hypersomnia, the dizziness and the digestive disorders do not occur, and a recurrence rate is less than 26%.
Owner:HEILONGJIANG ACAD OF TCM

Preparation method of medicine capable of moistening dryness and relieving itching

The invention discloses a preparation method of a medicine capable of moistening dryness and relieving itching. The raw materials of the medicine consist of traditional Chinese medicine materials of 50-300 parts of prepared polygonum multiflorum root tubers, 80-350 parts of polygonum multiflorum root tubers, 300-500 parts of unprepared rehmannia glutinosa root tubers, 80-350 parts of sophora flavescens roots, 80-350 parts of morus alba leaves and 50-200 parts of laportea bulbifera herbs. The preparation method comprises the steps of (1) taking the polygonum multiflorum root tubers, the prepared polygonum multiflorum root tubers and beta-CD, enabling the polygonum multiflorum root tubers, the prepared polygonum multiflorum root tubers and the beta-CD to dissolve in water, performing soaking, performing reflux extraction, performing concentrating to obtain an extracting solution, and performing spray drying to obtain spray dried powder 1 for standby application; and (2) adding water to the remaining four medicinal materials of the unprepared rehmannia glutinosa root tubers, the morus alba leaves and the like, performing soaking, performing decoction, performing filtration, performingconcentrating to obtain an extracting solution, performing spray drying to obtain spray dried powder 2, uniformly mixing the spray dried powder 2 with the spray dried powder 1 obtained through extraction and concentration of the polygonum multiflorum root tubers and the prepared polygonum multiflorum root tubers, and performing loading into capsules so as to obtain the medicine.
Owner:GUOYAOJITUAN TONGJITANG (GUIZHOU) PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products